Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year-Reference-Cited by-同舟云学术

Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year

Published:1990-10 Issue:5 Volume:3 Page:625-638
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Moncada Emilio,Subirá María Luisa,Oleaga Amelia,Goñi Fernando,Sánchez-Ibarrola Alfonso,Monreal Marta,Sevilla Marcela,Goñi María José,Yoldi Alfredo,Terán Diego,Llorente Ignacio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Effects of Cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset;Stiller;Science,1984

2. Cyclosporin increases the rate and length of remission in insulin-dependent diabetes of recent onset;Feutren;Lancet,1986

3. Factors associated with early remission of Type I Diabetes in children treated with Cyclosporine;Bougneres;N. Engl. J. Med.,1988

4. Cyclosporin-Induced Remission of IDDM after early intervention;Diabetes,1988

5. Direct effects of Cyclosporin A on Human Pancreatic B-cells;Nielsen;Diabetes,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Autoimmune Disease: The Type 1 Diabetes Paradigm;The Autoimmune Diseases;2020

2. Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes;Current Diabetes Reports;2016-08-15

3. Prevention of Autoimmune Disease;The Autoimmune Diseases;2014

4. Strategies in Immunotherapy of Insulin-Dependent Diabetes Mellitus;Annals of the New York Academy of Sciences;2006-12-17

5. Prevention of Autoimmune Disease: Type 1 Diabetes as a Paradigm;The Autoimmune Diseases;2006